Initial Public Offering and Private Placement (Details) - USD ($) |
1 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jun. 07, 2017 |
Jun. 05, 2019 |
Jun. 23, 2017 |
Sep. 30, 2019 |
|
| Initial Public Offering and Private Placement (Textual) | ||||
| Purchased an aggregate, shares | 125,000 | |||
| Proceeds from sale of units, gross proceeds | $ (100,000) | |||
| Sale of stock, per unit | $ 0.0225 | $ 10.10 | $ 10.00 | |
| Description of business acquisition equity | The Company's stockholders approved to further extend the period of time for which the Company is required to consummate a Business Combination from June 7, 2019 to September 9, 2019 (or December 9, 2019 if the Company has executed a definitive agreement for a Business Combination by September 9, 2019) or such earlier date as determined by the Board (the "Second Extension Amendment"). The number of shares of common stock presented for redemption in connection with the Second Extension Amendment was 1,580,762. The Company paid cash in the aggregate amount of $16,476,233, or approximately $10.42 per share, to redeeming stockholders. As a result of the payment on the shares of common stock presented for redemption in connection with the Second Extension Amendment, cash and marketable securities held in the Trust Account decreased to $49,993,473. | Subject to the terms and conditions of the Business Combination Agreement, at the Closing, the Company will acquire 100% of the outstanding equity and equity equivalents of CannBioRx (including options, warrants or other securities that have the right to acquire or convert into equity securities of the Company) in exchange for shares of KBL Common Stock (the “Transaction Shares”) valued at $175 million, subject to adjustment. Each Transaction Share will have a value equal to $10.00. The $175 million of consideration will be reduced by the amount of any liabilities of CannBioRx in excess of $5 million at the Closing. | ||
| Gross proceeds | $ (52,829,304) | |||
| Initial Public Offering [Member] | ||||
| Initial Public Offering and Private Placement (Textual) | ||||
| Initial public offering of units | 10,000,000 | 11,500,000 | ||
| Purchased an aggregate, shares | 1,500,000 | |||
| Proceeds from sale of units, gross proceeds | $ 100,000,000 | $ 115,000,000 | ||
| Sale of stock, per unit | $ 10.00 | $ 10.00 | ||
| Exercise price of warrant | $ 5.75 | |||
| Description of business acquisition equity | If the Company is unable to complete a Business Combination by the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders' rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company's obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. | |||
| Warrant, description | Each Warrant will entitle the holder to purchase one-half of one share of common stock at an exercise price of $5.75 per half share ($11.50 per whole share), subject to adjustment. No fractional shares will be issued upon exercise of the warrants. The Warrants will become exercisable on the later of (i) 30 days after the completion of the initial Business Combination and (ii) 12 months from the closing of the Initial Public Offering, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. | |||
| Warrant redemption, description | The Company may redeem the Warrants, in whole and not in part, at a price of $0.01 per Warrant upon 30 days' notice ("30-day redemption period"), only in the event that the last sale price of the common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice of redemption is given, provided there is an effective registration statement with respect to the shares of common stock underlying such Warrants and a current prospectus relating to those shares of common stock is available throughout the 30-day redemption period. | |||
| Business combination rights share | If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, each holder of a right will be required to affirmatively convert its rights in order to receive the 1/10 share of common stock underlying each right (without paying any additional consideration). | |||
| Private Placement [Member] | ||||
| Initial Public Offering and Private Placement (Textual) | ||||
| Initial public offering of units | 450,000 | |||
| Sale of stock, per unit | $ 10.00 | $ 10.00 | ||
| Gross proceeds | $ 4,500,000 | $ 525,000 | $ 4,500,000 | |
| Private Placement [Member] | Underwriters [Member] | ||||
| Initial Public Offering and Private Placement (Textual) | ||||
| Initial public offering of units | 125,000 | |||
| Private Placement [Member] | Sponsor [Member] | ||||
| Initial Public Offering and Private Placement (Textual) | ||||
| Initial public offering of units | 377,500 | |||
| Additional Placement Units [Member] | ||||
| Initial Public Offering and Private Placement (Textual) | ||||
| Purchased an aggregate, shares | 52,500 | |||
| Sale of stock, per unit | $ 10.00 | |||